178 related articles for article (PubMed ID: 28247750)
1. Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery.
Wu H; Jin H; Wang C; Zhang Z; Ruan H; Sun L; Yang C; Li Y; Qin W; Wang C
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9426-9436. PubMed ID: 28247750
[TBL] [Abstract][Full Text] [Related]
2. Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin.
Chen Y; Tezcan O; Li D; Beztsinna N; Lou B; Etrych T; Ulbrich K; Metselaar JM; Lammers T; Hennink WE
Nanoscale; 2017 Jul; 9(29):10404-10419. PubMed ID: 28702658
[TBL] [Abstract][Full Text] [Related]
3. Temperature/pH/Enzyme Triple-Responsive Cationic Protein/PAA-b-PNIPAAm Nanogels for Controlled Anticancer Drug and Photosensitizer Delivery against Multidrug Resistant Breast Cancer Cells.
Don TM; Lu KY; Lin LJ; Hsu CH; Wu JY; Mi FL
Mol Pharm; 2017 Dec; 14(12):4648-4660. PubMed ID: 29061050
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive charge-reversal MOF@polymer hybrid nanocomposites for enhanced co-delivery of chemotherapeutics towards combination therapy of multidrug-resistant cancer.
Hu L; Xiong C; Wei G; Yu Y; Li S; Xiong X; Zou JJ; Tian J
J Colloid Interface Sci; 2022 Feb; 608(Pt 2):1882-1893. PubMed ID: 34749141
[TBL] [Abstract][Full Text] [Related]
5. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
[TBL] [Abstract][Full Text] [Related]
7. Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed Nanogels.
Nguyen NT; Nguyen NNT; Tran NTN; Le PN; Nguyen TBT; Nguyen NH; Bach LG; Doan VN; Tran HLB; Le VT; Tran NQ
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567316
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive hyaluronic acid nanogels for hyperthermia- assisted chemotherapy to overcome multidrug resistance.
Li B; Xu Q; Li X; Zhang P; Zhao X; Wang Y
Carbohydr Polym; 2019 Jan; 203():378-385. PubMed ID: 30318226
[TBL] [Abstract][Full Text] [Related]
9. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653
[TBL] [Abstract][Full Text] [Related]
11. Dual-Targeting Polymeric Nanocarriers to Deliver ROS-Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells.
Xi L; Wang J; Wang Y; Ge Z
Macromol Biosci; 2021 Sep; 21(9):e2100091. PubMed ID: 34145971
[TBL] [Abstract][Full Text] [Related]
12. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs.
Surnar B; Jayakannan M
Biomacromolecules; 2016 Dec; 17(12):4075-4085. PubMed ID: 27936725
[TBL] [Abstract][Full Text] [Related]
13. Dual responsive magnetic composite nanogels for thermo-chemotherapy.
Indulekha S; Arunkumar P; Bahadur D; Srivastava R
Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-modified biocompatible Pullulan/poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells.
Ghaffarlou M; Sütekin SD; Karacaoğlu E; Karahisar Turan S; İnci ÖG; Güven O; Barsbay M
Eur J Pharm Biopharm; 2023 Mar; 184():189-201. PubMed ID: 36764499
[TBL] [Abstract][Full Text] [Related]
15. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
[TBL] [Abstract][Full Text] [Related]
16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.
Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y
Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883
[TBL] [Abstract][Full Text] [Related]
18. Self-Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma.
Zhang Y; Wang F; Li M; Yu Z; Qi R; Ding J; Zhang Z; Chen X
Adv Sci (Weinh); 2018 May; 5(5):1700821. PubMed ID: 29876208
[TBL] [Abstract][Full Text] [Related]
19. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation.
Misra R; Das M; Sahoo BS; Sahoo SK
Int J Pharm; 2014 Nov; 475(1-2):372-84. PubMed ID: 25178825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
